Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Murakami

Showing results (211-220 of 212) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 212 results.
Nature Communications|November 14, 2023
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptaseGang Liu, Tatt Jhong Haw, Malcolm R Starkey, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 22

Showing results (211-220 of 212) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 212 results.
Nature Communications|November 14, 2023
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptaseGang Liu, Tatt Jhong Haw, Malcolm R Starkey, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 22